Position in GHRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$160,662,969
+$88,450,177 QoQ
Shares Held
5,977,045
+16.4% QoQ
Ownership
8.71%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#4
of 62 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,384 across 370 Biotechnology names. GHRS ranks #73 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in GHRS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $160,662,969 | 5,977,045 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $72,212,792 | 5,136,045 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $65,227,771 | 5,136,045 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $76,176,743 | 5,327,045 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $62,073,247 | 5,092,145 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $46,872,866 | 4,249,580 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $17,411,590 | 2,487,370 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $18,367,026 | 2,745,445 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $34,587,920 | 2,966,374 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $32,140,635 | 3,015,069 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $18,193,840 | 3,136,869 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $32,516,463 | 3,235,469 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $48,960,505 | 4,126,465 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $34,161,410 | 4,275,521 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $43,312,133 | 4,455,981 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $58,247,165 | 5,012,665 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $49,273,215 | 4,937,196 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $95,153,613 | 5,202,494 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $118,762,903 | 5,090,566 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $50,384,244 | 2,283,964 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $29,589,610 | 1,361,694 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||